Apparent enhancement of perinatal transmission of human immunodeficiency virus type 1 by high maternal anti-gp160 antibody titer

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1737-1741

  Pancino, Gianfranco ^a   Leste Lasserre, Thierry ^b   Burgard, Marianne ^b   Costagliola, Dominique ^b   Ivanoff, Serge ^b   Blanche, Stéphane ^b   Rouzioux, Christine ^b   Sonigo, Pierre ^b  

^a INSTITUT COCHIN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PLACENTAL TRANSFER; PRIORITY JOURNAL; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 0031802439     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517435     Document Type: Article

References (15)

1. Kostrikis LG, Cao Y, Ngai H, Moore JP, Ho DD. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol 1996;70:445-58.
2. Homsy J, Meyer M, Levy JA. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol 1990;64:1437-40.
3. Zwart G, Van Der Hoek L, Valk M, et al. Antibody response to HIV-1 envelope and GAG epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Virology 1994;201:285-93.
4. Rossi P, Moschese V, Broliden PA, et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci USA 1989;86:8055-8.
5. Devash Y, Calvelli TA, Wood DG, Reagan KJ, Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci USA 1990;87:3445-9.
6. Scarlatti G, Albert J, Rossi P, et al. Mother-to-child transmission of human immunodeficiency virus. J Infect Dis 1993;168:207-10.
7. Parekh BS, Shaffer N, Pau CP, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS 1991;5:1179-84.
8. Robertson CA, Mok JYQ, Froebel KS, et al. Maternal antibodies to gp120 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis 1992;166:704-9.
9. Mabondzo A, Rouvier P, Raoul H, et al. Relationship between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants. Clin Exp Immunol 1995;102:476-80.
10. Lallemant M, Baillou A, Lallemant-Le Coeur S, et al. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet 1994;343:1001-5.
11. Markham RB, Coberly J, Ruff AJ, et al. Maternal IgGl and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission. Lancet 1994;343:390-1.
12. Gnann JW, Nelson JA, Oldstone MBA. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol 1987;61:2639-41.
13. Blanche S, Mayaux MJ, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994;330:308-12.
14. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. J Infect Dis 1997;175:172-5.
15. Kliks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994;272:467-74.